Functional antagonism and mapping of the P2X7 antagonist pocket
Cell-based study · Xenopus oocytes expressing human P2X7-2Nβ receptors, receptor chimeras/point mutants and human P2X1 control [1]
ATP-current inhibition and pocket mutations, interpreted with docking, support an allosteric binding model. This is a recombinant functional assay, not direct structural proof.
| Endpoint | Reported result | Reference |
|---|---|---|
| ATP EC90-evoked peak current inhibition at P2X7-2Nβ | pIC50 6.0 ± 0.05 (mean ± SEM; n = 4) | [1] |
| ATP EC90-evoked current inhibition at T94V | pIC50 <4 (n = 3) | [1] |
| ATP EC90-evoked current inhibition at D92A | pIC50 <4 (n = 3) | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- Concentration-response testing; 3 μM illustrated in Figure 1B. These are assay concentrations, not organism doses.
- Exposure duration
- ATP applied for 3 s at 3–5 min intervals; antagonist bath-perfused and coapplied.
- Method
- Voltage clamp at −60 mV in divalent-free ND96; receptor-specific ATP EC90 challenge.
- Co-treatment
- ATP agonist challenge; A740003 tested separately as a comparator.
- Reported limits
- Antagonist solvent and exact pre-exposure duration not specified in the acquired pharmacology methods.
Methods and source locations
Compound reported in the paper: A438079; Compound label in the paper: A438079
Supports active-compound pharmacology with reported hydrate qualifier; no salt conversion, hydration equivalence or Adooq lot validation.
Figure 1B–D; Table 1 (P2X7-2Nβ row); Figure 4A–B; Table 2 (T94V and D92A rows); Materials and Methods: Pharmacological Characterization/Data Analysis; Results: docking and pocket mutants
ATP EC90-evoked peak current inhibition at P2X7-2Nβ: Two-electrode voltage clamp; Hill fits to individual inhibition curves — Table 1, P2X7-2Nβ row; Data Analysis
ATP EC90-evoked current inhibition at T94V: Two-electrode voltage clamp — Table 2, T94V row; Figure 4A
ATP EC90-evoked current inhibition at D92A: Two-electrode voltage clamp — Table 2, D92A row; Figure 4A